Novocuff
Medical device company dedicated to improving pregnancy outcomes and reducing preterm births caused by PPROM and cervical shortening.
Launch date
Market cap
-
Enterprise valuation
$104—156m (Dealroom.co estimates Jul 2024.)
San Luis Obispo California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
* | N/A | $2.0m | Seed |
* | $26.0m | Series A | |
| Total Funding | $28.0m | ||